Showing 17,761 - 17,780 results of 28,274 for search '(( 50 ((na decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 12 men decrease ))', query time: 0.94s Refine Results
  1. 17761

    Intracellular chloride measurements by Wallace B Thoreson (5462)

    Published 2011
    “…An example of the reduction in MEQ fluorescence, indicating an increase in intracellular [Cl], produced by application of 12.1 mM Kto a cone. C. A greater decrease in MEQ fluorescence was produced by application of 69.9 mM K. …”
  2. 17762

    Oosthuizen et al. Data.pdf by Tasha Oosthuizen (19200784)

    Published 2024
    “…When the night light originated remotely from a corner of the room, activity levels decreased by more than 50%, whereas under direct ALAN from above the cages, there was a 75% decrease in activity. …”
  3. 17763

    Correlational learning rule for regulation of vestibular synapse strength by cerebellar inhibition: transfer of VOR gain from cerebellar cortex to brainstem. by John R. W. Menzies (361198)

    Published 2013
    “…During training the cerebellum has learnt to produce an inhibitory input modulated in phase with the vestibular input, leading to cancellation which produces a 50% gain decrease (since and , a weight requires ). …”
  4. 17764

    Functional Lung Imaging during HFV in Preterm Rabbits by Jordan Thurgood (123527)

    Published 2012
    “…Whilst ventilated at fixed pressures, each animal was ventilated at frequencies of 1, 3, 5 and 10 Hz. A 50% decrease in delivered tidal volume was measured at 10 Hz compared to 1 Hz, yet at the higher frequency a 500% increase in minute activity was measured. …”
  5. 17765

    Substrate binding specificity of purified OpuAC. by Justina C. Wolters (207763)

    Published 2010
    “…The inhibition experiments with proline and carnitine show a decrease in the ΔF<sub>max</sub> at increased concentrations of inhibitor, which is caused by the high concentrations of inhibitor (see panel A and B). …”
  6. 17766

    Data_Sheet_1_Drug-Tolerant Idling Melanoma Cells Exhibit Theory-Predicted Metabolic Low-Low Phenotype.docx by Dongya Jia (3897142)

    Published 2020
    “…L/L metabolism is unfavorable for tumor growth, yet supports successful cell division at ~50% rate. Thus, L/L drug-tolerant idling cells are a reservoir for accumulating mutations responsible for relapse, and it should be considered as a target subpopulation for improving MAPKi outcomes in melanoma treatment.…”
  7. 17767

    Results of experiment 3&4—Flanker experiments with predictable and unpredictable timing. by Klaas Bombeke (3927152)

    Published 2017
    “…<p>(A)(B) Mean reaction times per SOA condition (irrelevant-first, simultaneous and relevant-first in experiment 1, (A); irrelevant-first in experiment 2, (B)) for current congruent (dark grey) and incongruent (light grey) trials as a function of the congruency level of the previous trial in the Flanker experiments (error bars represent 1 standard deviation around the mean). …”
  8. 17768
  9. 17769
  10. 17770

    The schema for simultaneous measurement of calcium oscillations in 96-well plates and methods for extracting wave features. by Richi Sakaguchi (15374510)

    Published 2023
    “…Peak Width was the time from the point at which the peak starts rising to the time when the signal decreased to 10% of the peak height. Mean Peak Width 50% was the time from the maximum value to the time when the signal decreased to the half of this value. …”
  11. 17771
  12. 17772
  13. 17773
  14. 17774
  15. 17775
  16. 17776
  17. 17777
  18. 17778

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  19. 17779
  20. 17780

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”